ICON (ICLR) vs NRC Health (NRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
NRC Health (NRC) has outperformed ICON (ICLR) over the past year, gaining 42.5% versus a gain of 13.5%. Over five years, ICLR leads with a -31.4% price change compared with -39.0% for NRC. ICON is the larger company by market cap ($13.99 billion vs $533.9 million), about 26.2 times the size.
On valuation, ICON trades at a lower forward P/E (16.1x vs 23.7x for NRC Health). NRC Health pays a dividend yielding 2.54%, while ICON does not currently pay one. NRC Health converts more of its revenue into profit, with a net margin of 8.4% versus 2.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICLR | NRC |
|---|---|---|
| Share price | $186.71 | $25.16 |
| Market cap | $13.99B | $533.93M |
| 1-day change | -1.92% | +0.68% |
| YTD return | +2.46% | +34.04% |
| 1-year return | +13.46% | +42.47% |
| 5-year return | -31.36% | -38.98% |
| P/E ratio (TTM) | 74.68 | 93.19 |
| Forward P/E | 16.09 | 23.74 |
| EPS (TTM) | $2.50 | $0.27 |
| Dividend yield | 0.00% | 2.54% |
| Annual dividend | $0.00 | $0.64 |
| Revenue (latest FY) | $8.25B | $137.39M |
| Revenue growth (YoY) | +0.76% | -3.96% |
| Net income (latest FY) | $229.34M | $11.60M |
| Gross margin | 26.37% | — |
| Operating margin | 5.37% | 16.44% |
| Net margin | 2.78% | 8.44% |
| 52-week high | $219.04 | $27.60 |
| 52-week low | $66.57 | $11.74 |
| Distance from 52-week high | -14.76% | -8.84% |
| Analyst consensus | buy | none |
| Avg. price target upside | +23.88% | +7.31% |
| Average volume | 989.87K | 110.81K |
| Shares outstanding | 74.92M | 21.22M |
| Employees | 40,250 | 357 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICON is about 26.2 times larger than NRC Health by market value ($13.99B vs $533.93M).
- NRC has outperformed ICLR by 29.0 percentage points over the past year.
- NRC Health offers a meaningfully higher dividend yield (2.54% vs 0.00%).
- NRC Health is more profitable, keeping 8.4 cents of every revenue dollar as net income versus 2.8 cents for ICON.
About ICON
ICLR stock →ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 40,250 employees
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
ICLR vs NRC FAQ
Which is bigger, ICON or NRC Health?
ICON (ICLR) is larger, with a market capitalization of $13.99B compared with $533.93M for NRC Health (NRC).
Which stock has performed better over the past year, ICLR or NRC?
NRC returned +42.47% over the past 12 months, compared with +13.46% for ICLR (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ICLR or NRC?
ICLR has the lower trailing P/E at 74.7, versus 93.2 for NRC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, ICON or NRC Health?
NRC Health pays a dividend yielding 2.54%, while ICON does not currently pay a regular dividend.
Are ICON and NRC Health in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.